139 related articles for article (PubMed ID: 9427334)
1. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey.
Martins AP; Marras RA; Guimarães FS
Neuroreport; 1997 Nov; 8(16):3601-4. PubMed ID: 9427334
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray.
Martins AP; Marras RA; Guimarães FS
Depress Anxiety; 2000; 12(2):99-101. PubMed ID: 11091933
[TBL] [Abstract][Full Text] [Related]
3. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
Kask A; Rägo L; Harro J
Neuroreport; 1997 Nov; 8(16):3645-7. PubMed ID: 9427342
[TBL] [Abstract][Full Text] [Related]
4. Alpha-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats.
Jahn H; Montkowski A; Knaudt K; Ströhle A; Kiefer F; Schick M; Wiedemann K
Brain Res; 2001 Mar; 893(1-2):21-8. PubMed ID: 11222988
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
De Araújo JE; Huston JP; Brandão ML
Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
[TBL] [Abstract][Full Text] [Related]
6. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Netto CF; Guimarães FS
Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
[TBL] [Abstract][Full Text] [Related]
7. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask A; Rägo L; Harro J
Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
[TBL] [Abstract][Full Text] [Related]
8. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
Miguel TT; Nunes-de-Souza RL
Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
[TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of "vehicle" microinjected into the dorsal periaqueductal grey of rats tested in the elevated plus maze.
Matheus MG; de-Lacerda JC; Guimarães FS
Braz J Med Biol Res; 1997 Jan; 30(1):61-4. PubMed ID: 9222404
[TBL] [Abstract][Full Text] [Related]
10. The dorsal periaqueductal gray modulates the increased fear-like behavior exhibited by experienced rats in the elevated plus-maze.
Kincheski GC; Carobrez AP
Behav Brain Res; 2010 Jan; 206(1):120-6. PubMed ID: 19737580
[TBL] [Abstract][Full Text] [Related]
11. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
Borelli KG; Brandão ML
Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
[TBL] [Abstract][Full Text] [Related]
12. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
[TBL] [Abstract][Full Text] [Related]
13. Anxiogenic-like effect of glycine and D-serine microinjected into dorsal periaqueductal gray matter of rats.
Schmitt ML; Coelho W; Lopes-de-Souza AS; Guimarães FS; Carobrez AP
Neurosci Lett; 1995 Apr; 189(2):93-6. PubMed ID: 7609926
[TBL] [Abstract][Full Text] [Related]
14. Brain corticotropin-releasing hormone increases arousal in stress.
Shibasaki T; Yamauchi N; Hotta M; Imaki T; Oda T; Ling N; Demura H
Brain Res; 1991 Jul; 554(1-2):352-4. PubMed ID: 1933317
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats.
Pelosi GG; Resstel LL; Soares VP; Zangrossi H; Guimarães FS; Corrêa FM
Behav Pharmacol; 2009 May; 20(3):252-9. PubMed ID: 19407657
[TBL] [Abstract][Full Text] [Related]
16. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
Sergio Tde O; Spiacci A; Zangrossi H
Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
[TBL] [Abstract][Full Text] [Related]
17. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
Rassnick S; Heinrichs SC; Britton KT; Koob GF
Brain Res; 1993 Mar; 605(1):25-32. PubMed ID: 8467387
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
[TBL] [Abstract][Full Text] [Related]
19. Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior.
Bruijnzeel AW; Stam R; Wiegant VM
Psychopharmacology (Berl); 2001 Nov; 158(2):132-9. PubMed ID: 11702086
[TBL] [Abstract][Full Text] [Related]
20. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors.
Soares Vde P; Campos AC; Bortoli VC; Zangrossi H; Guimarães FS; Zuardi AW
Behav Brain Res; 2010 Dec; 213(2):225-9. PubMed ID: 20457188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
